Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Ambulatory care in Germany: Randomized controlled trials meet clinical practice.

Marschner, N., 2009.

Onkologie 32 (suppl 4)(V21), 3. doi:10.1159/000242462

Abstract

Indikation: Other, Sonstige / Veranstaltung: DGHO / Journal: Onkologie
Registerübergreifend
2009
Epidemiologisches Register zur Darstellung der Behandlungsrealität und der Therapiemodalitäten beim behandlungsbedürftigen metastasiertenoder lokal fortgeschrittenen Nierenzellkarzinom.

Köhler, 2009.

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: AKS Studientreffen / Journal: -
TNK
2009
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.

Knauf, W.U., Lissichkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranov, S., Becker, M., Fricke, H.-J., Huguet, F., Del Giudice, I., Klein, P., Tremmel, L., Merkle, K., Montillo, M., 2009.

J Clin Oncol 27, 4378–4384. doi:10.1200/JCO.2008.20.8389

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: - / Journal: Journal of Clinical Oncology
02 CLL III
2009
Bendamustine in the treatment of chronic lymphocytic leukemia.

Knauf, W., 2009

Expert Rev Anticancer Ther 9, 165–174. doi:10.1586/14737140.9.2.165

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: - / Journal: Expert Review of Anticancer Therapy
02 CLL III
2009
The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial.

Hadji, P., Ziller, M., Kieback, D.G., Menschik, T., Kalder, M., Kuck, J., Hasenburg, A., 2009.

Breast 18, 159–164. doi:10.1016/j.breast.2009.03.003

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: The Breast
TEAM
2009
Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy.

Hadji, P., Ziller, M., Kieback, D.G., Dornoff, W., Tessen, H.W., Menschik, T., Kuck, J., Melchert, F., Hasenburg, A., 2009.

Ann Oncol 20, 1203–1209. doi:10.1093/annonc/mdn762

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Annals of Oncology
TEAM
2009
The treatment of colorectal cancer in German outpatient centres. Data from a clinical registry. A joint project of the AIO and the AKS.

Freier, W., Schröder, J., Rauh, J., Harich, H.-D., Hartmann, H., 2009.

Onkologie 32 (suppl 4)(P197), 47. doi:10.1159/000242462

Abstract

Download

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TKK
2009
Gemcitabine plus vinorelbine versus gemcitabine plus cisplatin versus gemcitabine plus capecitabine: A randomized trial in pretreated metastatic breast cancer.

Freier, W., Stemmler, H.-J., Tessen, H.-W., Gitsch, G., Jonat, W., Bruger, W., Kettner, E., Tesch, H., Abenhardt, W., Heinemann, V., 2008.

Onkologie 31 (suppl 4)(P470), 164. doi:10.1159/000161588

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Onkologie
Gemcitabine 02 MC
2008
Quality of life in relation to hormonal treatment of postmenopausal women in the Dutch subset of the TEAM Trial.

van Nes, J., Voskuil, D., Putter, H., van Leeuwen, F., Junggeburt, J., Hille, E., de Haes, H., van de Velde, C., 2008.

Cancer Res 69(2 Supplement), 21. doi:10.1158/0008-5472.SABCS-21

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Bendamustine versus chlorambucil as first-line treatment in B cell chronic lymphocytic leukemia: An updated analysis from an international phase III study.

Knauf, W.U., Lissitchkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranov, S., Becker, M., Hoeffken, K., Huguet, F., Foa, R., Merkle, K., Montillo, M., 2008.

Blood 112(11), 2091.

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
02 CLL III
2008